Sign in

    Adam Rusckowski

    Vice President and Equity Research Analyst at Bank of America

    Adam Rusckowski is a Vice President and Equity Research Analyst at Bank of America, specializing in coverage of the healthcare diagnostics and life sciences tools sector. He provides research and investment recommendations on key companies such as Quest Diagnostics, among other industry leaders, with a focus on analyzing sector trends and company fundamentals. Rusckowski joined Bank of America as an equity analyst and has developed expertise in the diagnostics space, leveraging his background in biomedical engineering to provide data-driven insights to institutional clients. He holds professional certifications relevant to the financial industry, including active FINRA securities licenses.

    Adam Rusckowski's questions to TEEKAY TANKERS (TNK) leadership

    Adam Rusckowski's questions to TEEKAY TANKERS (TNK) leadership • Q2 2024

    Question

    Adam Rusckowski, on behalf of Ken Hexter at Bank of America, asked about the sustainability of LR2 tankers shifting to the clean product trade and its tightening effect on the Aframax market. He also questioned if the initial voyages from the Trans Mountain pipeline have altered the company's long-term ton-mile outlook.

    Answer

    CEO Kevin Mackay described LR2s as fungible assets that move between crude and clean trades based on earnings, suggesting the current shift is not a short-term phenomenon due to expected strength in the product tanker market. Director of Research Christian Waldegrave added that while the TMX pipeline is not yet at full capacity, it has already boosted Aframax demand, and he expects a greater ton-mile impact as volumes increase and more long-haul voyages to Asia are established.

    Ask Fintool Equity Research AI